| 标题 |
 Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
璐璐
v0id
牧青
invisight
DW
林狗
aaaa
lalala
aajhajkahna
谢雷XIELei
嘻嘻哈哈
愉快的真
OK
学霸业
pluto
学术文献互助
乐空思
极限001
GingerF
fangyuan
皖公网安备34019202002308
